Back to Journals » International Journal of Nanomedicine » Volume 19

The New Nano-Resuscitation Solution (TPP-MR) Attenuated Myocardial Injury in Hemorrhagic Shock Rats by Inhibiting Ferroptosis [Corrigendum]

Authors Tan L, She H , Wang Y, Du Y, Zhang J, Du Y, Wu Y , Chen W, Huang B, Long D, Peng X, Li Q, Mao Q , Li T, Hu Y

Received 14 August 2024

Accepted for publication 14 August 2024

Published 17 August 2024 Volume 2024:19 Pages 8401—8402

DOI https://doi.org/10.2147/IJN.S491496



Tan L, She H, Wang Y, et al. Int J Nanomedicine. 2024;19:7567–7583.

The authors have advised due to an error that occurred inadvertently at the time of figure assembly, figure parts 3D and 3E on page 7575 are incorrect.

The correct Figure 3 is as follows.

Figure 3 Continued.

Figure 3 Mitochondrial function of cardiomyocytes hemorrhagic shock. (A) Changes in the ATP level (3 independent experiments). (B and C) Mitochondrial maximum respiratory rate assay in H9C2 (3 independent experiments). (D) Representative images of mitochondrial morphology of H9C2 cells (bar, 20um, 3 independent experiments). (E) The mitochondrial membrane potential of H9C2 was observed by confocal microscopy (bar, 20um, 3 independent experiments). (F) Red/green fluorescent (Δψm) quantitative analysis in H9C2. (G) Representative confocal images of MITO-SOX (bar, 10um, 3 independent experiments). (H) ROS fluorescence quantitative analysis in H9C2. aP<0.05 compared with the normal group, bP<0.05 compared with the hypoxia group.

The authors apologize for these errors and advise they do not impact the conclusion of the study.


Read the original article


Creative Commons License © 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, 3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.